Gonorrhoea in 21st century – international and Polish situation
Journal Title: Przegląd Epidemiologiczny - Year 2014, Vol 68, Issue 1
Abstract
Gonorrhoea, according to the latest World Health Organization (WHO) estimates in 2008, is the most frequent bacterial sexually transmitted infection globally, accounting for 106.1 million new cases among adults. Of those cases, 3.4 (3.2%) million were in the WHO European Region. In the European Union and European Economic Area, the incidence of reported cases was 12.6 per 100,000 inhabitants in 2011. The highest incidences were noted in the United Kingdom (37.1), Latvia (24.4) and Ireland (18.6). However, in Poland from 2000 to 2011 the reported incidence declined and was only 0.8-0.9 per 100,000 inhabitants in 2011, that might indicate a suboptimal diagnostics and incomplete case reporting and epidemiological surveillance. A study surveying the diagnostics for gonorrhoea and the case reporting system, including the local and national epidemiological surveillance, in Poland is recommended. The high resistance in Neisseria gonorrhoeae to nearly all antimicrobials introduced for treatment of gonorrhoea is an exceedingly serious problem globally. A few years ago the first extensively-drug resistant N. gonorrhoeae strains with high-level resistance to ceftriaxone, the last remaining option for firstline empirical monotherapy, were reported. Due to this emergent situation, in 2012 the WHO and the European Centre for Disease Prevention and Control (ECDC) launched a global action plan and regional response plan, respectively, to combat the spread of multidrug resistant N. gonorrhoeae. Additionally, an updated European guideline on the diagnosis and treatment of gonorrhoea, recommending treatment with ceftriaxone together with azithromycin, was published in 2012. Worryingly, no antimicrobial susceptibility data for N. gonorrhoeae strains circulating in Poland have been internationally reported in several decades. It is imperative to implement some regular and quality assured antimicrobial susceptibility surveillance for N. gonorrhoeae in Poland and the official Polish treatment guidelines (from 1970s) recommending penicillin G as first-line treatment for gonorrhoea need to be promptly revised.
Authors and Affiliations
Agnieszka B Serwin, Marta Koper, Magnus Unemo
Keywords
Related Articles
- EP ID EP72590
- DOI -
- Views 109
- Downloads 0
Hepatitis B in Poland in 2015 / Wirusowe zapalenie wątroby typu B w Polsce w 2015 roku
OBJECTIVE: Assessment of the epidemiological situation of hepatitis B in Poland in 2015 in relation to previous years. MATERIAL AND METHODS: Evaluation of the epidemiological situation carried out based on analysis of da...
The role of alert pathogens in bacterial diseases in patients hospitalized at the Department of Pulmonary Diseases and Tuberculosis Public Clinical Hospital No 3 in Zabrze in 2008-2012 / Rola patogenów alarmowych w chorobach bakteryjnych u pacjentów hospitalizowanych w Katedrze i Klinice Chorób Płuc i Gruźlicy Samodzielnego Publicznego Szpitala Klinicznego w Zabrzu w latach 2008-2012
BACKGROUND: The current public health problem is the increasing bacterial resistance to antibiotics. Microorganisms isolated from infections are more often non-susceptible to most available drugs. The microorganisms prod...
Metodologia szacowania kosztów pośrednich w ocenie ekonomicznej starzenia sie społeczeństwa - specyfika oceny
Proces starzenia demograficznego szczególnie w ostatnich dziesięcioleciach nabiera większej dynamiki oraz znaczenia, z uwagi na rosnące potrzeby zdrowotne i oczekiwania gwarancji świadczeń społecznych. Wypracowanie najba...
Long-term outcomes of thyroid dysfunction in patients with chronić hepatitis C treated with pegylated interferon alpha and ribavirin / Długoterminowa obserwacja zaburzeń funkcji tarczycy u pacjentów przewlekle zakażonych HCV leczonych pegylowanym i interferonem alfa i rybawiryną
INTRODUCTION: Thyroid dysfunctions (TDs) are associated with pegylated interferon and ribavirin (PegIFN-α/RBV) therapy in patients with chronic hepatitis C (CHC) and are considered as possible extrahepatic manifestation...
Tężec w Polsce w 2013 roku
Tężec jest chorobą zakaźną, która mimo niewielkiej liczby zachorowań stanowi trwałe zagrożenie dla osób nieszczepionych. Ciężkość choroby wiąże się z wysoką śmiertelnością, szczególnie u osób w starszych grupach wieku. C...